Ikapharmindo Putramas Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp197 (market cap 330.19B, 135.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ikapharmindo Putramas Tbk. is more actively traded (135.9K versus 43.9K). Which is the better fit depends on your goals.
| IKPM | OBAT | |
|---|---|---|
Market Cap | 330.19B | 164.65B |
Volume | 135.9K | 43.9K |
Lot | 1.36K | 439 |
Turnover | 26.77M | 10.6M |
Average Price | 197 | 241.43 |
Value | 26.77M | 10.6M |
Indicative Equilibrium Price | 195 | 238 |
Indicative Equilibrium Volume | 1 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →